CD4 and neoplasm: In the tumor microenvironment, PD-L1+TAMs, and programmed cell death protein-1 (PD-1)+ CD4+ T cells are present, in contact with PD-L1+ tumor cells, supporting a possible role of the TAMs in the mechanism of action of checkpoint inhibitor therapy [30].